{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:13:14Z","timestamp":1794024794002,"version":"4.8.0"},"reference-count":225,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009888","name":"Regione Toscana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bcp.2021.114812","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T12:17:46Z","timestamp":1634818666000},"page":"114812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients"],"prefix":"10.1016","volume":"193","author":[{"given":"Chiara","family":"Giacomelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Piccarducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Romei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bcp.2021.114812_b0005","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of Fibrotic Lung Diseases","volume":"383","author":"Drazen","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1183\/09031936.00069307","article-title":"Idiopathic Pulmonary Fibrosis: Multiple Causes and Multiple Mechanisms?","volume":"30","author":"Maher","year":"2007","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.bcp.2021.114812_b0015","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1172\/JCI60323","article-title":"Pulmonary Fibrosis: Patterns and Perpetrators","volume":"122","author":"Noble","year":"2012","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.bcp.2021.114812_b0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/17476348.2019.1623028","article-title":"Pulmonary Fibrosis: A Disease of Alveolar Collapse and Collagen Deposition","volume":"13","author":"Snijder","year":"2019","journal-title":"Expert Review of Respiratory Medicine"},{"issue":"2","key":"10.1016\/j.bcp.2021.114812_b0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1165\/rcmb.2020-0373PS","article-title":"The Interplay of the Genetic Architecture, Aging, and Environmental Factors in the Pathogenesis of Idiopathic Pulmonary Fibrosis","volume":"64","author":"Pardo","year":"2021","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.bcp.2021.114812_b0030","doi-asserted-by":"crossref","first-page":"L257","DOI":"10.1152\/ajplung.00238.2020","article-title":"Healing after COVID-19: Are Survivors at Risk for Pulmonary Fibrosis?","volume":"320","author":"McDonald","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b0035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijtb.2020.11.003","article-title":"Post Covid 19 Pulmonary Fibrosis. Is It Real Threat?","volume":"68","author":"Rai","year":"2021","journal-title":"Indian Journal of Tuberculosis"},{"issue":"8","key":"10.1016\/j.bcp.2021.114812_b0040","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41401-020-00566-4","article-title":"Pulmonary Fibrosis in Critically Ill Patients with Novel Coronavirus Pneumonia during the Convalescent Stage and a Proposal for Early Intervention","volume":"42","author":"Zou","year":"2021","journal-title":"Acta Pharmacol Sin"},{"issue":"135","key":"10.1016\/j.bcp.2021.114812_b0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1183\/09059180.00003214","article-title":"Cellular Interactions in the Pathogenesis of Interstitial Lung Diseases","volume":"24","author":"Bagnato","year":"2015","journal-title":"European Respiratory Review"},{"key":"10.1016\/j.bcp.2021.114812_b0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mam.2018.06.003","article-title":"Organ and Tissue Fibrosis: Molecular Signals, Cellular Mechanisms and Translational Implications","volume":"65","author":"Weiskirchen","year":"2019","journal-title":"Mol Aspects Med"},{"issue":"4","key":"10.1016\/j.bcp.2021.114812_b0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s43152-020-00022-9","article-title":"Origin of Myofibroblasts in Lung Fibrosis","volume":"1","author":"Hung","year":"2020","journal-title":"Curr. Tissue Microenviron. Rep."},{"key":"10.1016\/j.bcp.2021.114812_b0060","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1755-1536-5-S1-S5","article-title":"The Myofibroblast, Multiple Origins for Major Roles in Normal and Pathological Tissue Repair","volume":"5","author":"Micallef","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.bcp.2021.114812_b0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11926-018-0710-z","article-title":"Matrix Stiffness: The Conductor of Organ Fibrosis","volume":"20","author":"Santos","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.bcp.2021.114812_b0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1165\/rcmb.2013-0152OC","article-title":"Endothelial Cells Recruit Macrophages and Contribute to a Fibrotic Milieu in Bleomycin Lung Injury","volume":"49","author":"Leach","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.amjms.2019.01.010","article-title":"Epithelial Injury and Dysfunction in the Pathogenesis of Idiopathic PulmonaryFibrosis","volume":"357","author":"Winters","year":"2019","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-021-01650-x","article-title":"The Role of Viral and Bacterial Infections in the Pathogenesis of IPF: A Systematic Review and Meta-Analysis","volume":"22","author":"Mostafaei","year":"2021","journal-title":"Respir. Res."},{"key":"10.1016\/j.bcp.2021.114812_b0085","doi-asserted-by":"crossref","first-page":"103470","DOI":"10.1016\/j.ebiom.2021.103470","article-title":"Fibrotic Lung Disease: A Molecular Glimpse into Severe Covid-19?","volume":"69","author":"Spagnolo","year":"2021","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.bcp.2021.114812_b0090","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13196","article-title":"Vascular Dysfunction in Aged Mice Contributes to Persistent Lung Fibrosis","volume":"19","author":"Caporarello","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.bcp.2021.114812_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic Sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bcp.2021.114812_b0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12929-019-0580-3","article-title":"Active Roles of Dysfunctional Vascular Endothelium in Fibrosis and Cancer","volume":"26","author":"Hsu","year":"2019","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ni.3341","article-title":"The Development and Maintenance of Resident Macrophages","volume":"17","author":"Perdiguero","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bcp.2021.114812_b0110","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3389\/fimmu.2017.01520","article-title":"Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia","volume":"8","author":"Amici","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2021.114812_b0115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12931-018-0864-2","article-title":"Macrophages: Friend or Foe in Idiopathic Pulmonary Fibrosis?","volume":"19","author":"Zhang","year":"2018","journal-title":"Respir Res"},{"issue":"7","key":"10.1016\/j.bcp.2021.114812_b0120","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.200509-1518OC","article-title":"A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18","volume":"173","author":"Prasse","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.bcp.2021.114812_b0125","doi-asserted-by":"crossref","first-page":"1802441","DOI":"10.1183\/13993003.02441-2018","article-title":"Proliferating SPP1\/MERTK-Expressing Macrophages in Idiopathic Pulmonary Fibrosis","volume":"54","author":"Morse","year":"2019","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.bcp.2021.114812_b0130","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1371\/journal.pmed.0020251","article-title":"Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis","volume":"2","author":"Pardo","year":"2005","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in Tissue Repair, Regeneration, and Fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"issue":"7635","key":"10.1016\/j.bcp.2021.114812_b0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature20611","article-title":"Identification of an Atypical Monocyte and Committed Progenitor Involved in Fibrosis","volume":"541","author":"Satoh","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b0145","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2020.02.007","article-title":"Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis","volume":"52","author":"Fukushima","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b0150","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.2011.166","article-title":"The Distribution of Immunomodulatory Cells in the Lungs of Patients with Idiopathic Pulmonary Fibrosis","volume":"25","author":"Nuovo","year":"2012","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1073\/pnas.1315854111","article-title":"IL-25 and Type 2 Innate Lymphoid Cells Induce Pulmonary Fibrosis","volume":"111","author":"Hams","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.bcp.2021.114812_b0160","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","article-title":"IL-33 Promotes ST2-Dependent Lung Fibrosis by the Induction of Alternatively Activated Macrophages and Innate Lymphoid Cells in Mice","volume":"134","author":"Li","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bcp.2021.114812_b0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.imlet.2017.08.022","article-title":"Innate Lymphoid Cells and Fibrotic Regulation","volume":"195","author":"Horsburgh","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bcp.2021.114812_b0170","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.194.6.809","article-title":"Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor Beta(1)","volume":"194","author":"Lee","year":"2001","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.bcp.2021.114812_b0175","doi-asserted-by":"crossref","first-page":"1802111","DOI":"10.1183\/13993003.02111-2018","article-title":"Targeting Interleukin-13 in Idiopathic Pulmonary Fibrosis: From Promising Path to Dead End","volume":"52","author":"Wijsenbeek","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 Immunity in Tissue Repair and Fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1016\/j.bcp.2021.114812_b0185","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.4049\/jimmunol.1000675","article-title":"A Novel Mechanism of Rapid Nuclear Neutrophil Extracellular Trap Formation in Response to Staphylococcus Aureus","volume":"185","author":"Pilsczek","year":"2010","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.bcp.2021.114812_b0190","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nm.2847","article-title":"Infection-Induced NETosis Is a Dynamic Process Involving Neutrophil Multitasking in Vivo","volume":"18","author":"Yipp","year":"2012","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.bcp.2021.114812_b0195","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil Extracellular Traps in Immunity and Disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.bcp.2021.114812_b0200","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.4049\/jimmunol.1201719","article-title":"Neutrophil Extracellular Traps: Double-Edged Swords of Innate Immunity","volume":"189","author":"Kaplan","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2021.114812_b0205","doi-asserted-by":"crossref","first-page":"41749","DOI":"10.1038\/srep41749","article-title":"Transcriptional Firing Helps to Drive NETosis","volume":"7","author":"Khan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bcp.2021.114812_b0210","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3390\/biom5020702","article-title":"The Role of Reactive Oxygen Species (ROS) in the Formation of Extracellular Traps (ETs) in Humans","volume":"5","author":"Stoiber","year":"2015","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/01902149109063278","article-title":"Interleukin-8 (IL-8): The Major Neutrophil Chemotactic Factor in the Lung","volume":"17","author":"Kunkel","year":"1991","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.bcp.2021.114812_b0220","doi-asserted-by":"crossref","unstructured":"Leslie, J.; Millar, B.J.M.; Pons, A. del C.; Burgoyne, R.A.; Frost, J.D.; Barksby, B.S.; Luli, S.; Scott, J.; Simpson, A.J.; Gauldie, J.; et al. FPR-1 Is an Important Regulator of Neutrophil Recruitment and a Tissue-Specific Driver of Pulmonary Fibrosis. JCI Insight 2020, 5, doi:10.1172\/jci.insight.125937.","DOI":"10.1172\/jci.insight.125937"},{"key":"10.1016\/j.bcp.2021.114812_b0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fimmu.2013.00161","article-title":"IL-15 Fosters Age-Driven Regulatory T Cell Accrual in the Face of Declining IL-2 Levels","volume":"4","author":"Raynor","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.bcp.2021.114812_b0230","doi-asserted-by":"crossref","unstructured":"Barnes, B.J.; Adrover, J.M.; Baxter-Stoltzfus, A.; Borczuk, A.; Cools-Lartigue, J.; Crawford, J.M.; Da\u00dfler-Plenker, J.; Guerci, P.; Huynh, C.; Knight, J.S.; et al. Targeting Potential Drivers of COVID-19: Neutrophil Extracellular Traps. J Exp Med 2020, 217, e20200652, doi:10.1084\/jem.20200652.","DOI":"10.1084\/jem.20200652"},{"key":"10.1016\/j.bcp.2021.114812_b0235","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201012","article-title":"Neutrophil Extracellular Traps Infiltrate the Lung Airway, Interstitial, and Vascular Compartments in Severe COVID-19","volume":"217","author":"Radermecker","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2021.114812_b0240","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3389\/fimmu.2020.02190","article-title":"Identification of a Novel HIF-1\u03b1-\u0391M\u03b22 Integrin-NET Axis in Fibrotic Interstitial Lung Disease","volume":"11","author":"Khawaja","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0245","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaci.2010.12.1103","article-title":"Eosinophil and Neutrophil Extracellular DNA Traps in Human Allergic Asthmatic Airways","volume":"127","author":"Dworski","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.bcp.2021.114812_b0250","doi-asserted-by":"crossref","first-page":"e90042","DOI":"10.1371\/journal.pone.0090042","article-title":"Escherichia Coli and Candida Albicans Induced Macrophage Extracellular Trap-like Structures with Limited Microbicidal Activity","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0255","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF02147594","article-title":"Presence of Modified Fibroblasts in Granulation Tissue and Their Possible Role in Wound Contraction","volume":"27","author":"Gabbiani","year":"1971","journal-title":"Experientia"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bcp.2021.114812_b0265","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/thoraxjnl-2013-204608","article-title":"Epithelial-Mesenchymal Transition in Lung Development and Disease: Does It Exist and Is It Important?","volume":"69","author":"Bartis","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.bcp.2021.114812_b0270","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fphar.2018.00054","article-title":"The A2B Adenosine Receptor Modulates the Epithelial\u2013 Mesenchymal Transition through the Balance of CAMP\/PKA and MAPK\/ERK Pathway Activation in Human Epithelial Lung Cells","volume":"9","author":"Giacomelli","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114812_b0275","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jb\/mvr136","article-title":"TGF-\u03b2-Induced Epithelial-Mesenchymal Transition of A549 Lung Adenocarcinoma Cells Is Enhanced by pro-Inflammatory Cytokines Derived from RAW 264.7 Macrophage Cells","volume":"151","author":"Kawata","year":"2012","journal-title":"J Biochem"},{"issue":"35","key":"10.1016\/j.bcp.2021.114812_b0280","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1073\/pnas.0605669103","article-title":"Alveolar Epithelial Cell Mesenchymal Transition Develops in Vivo during Pulmonary Fibrosis and Is Regulated by the Extracellular Matrix","volume":"103","author":"Kim","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2021.114812_b0285","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3892\/ijmm.2021.4965","article-title":"TGF-\u03b21: Gentlemanly Orchestrator in Idiopathic Pulmonary Fibrosis (Review)","volume":"48","author":"Ye","year":"2021","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bcp.2021.114812_b0290","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-Dependent and Smad-Independent Pathways in TGF-Beta Family Signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0295","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1734","article-title":"Activation of Canonical Wnt Signalling Is Required for TGF-\u03b2-Mediated Fibrosis","volume":"3","author":"Akhmetshina","year":"2012","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.bcp.2021.114812_b0300","doi-asserted-by":"crossref","first-page":"7026","DOI":"10.1074\/jbc.M111.276311","article-title":"Interactions between \u03b2-Catenin and Transforming Growth Factor-\u03b2 Signaling Pathways Mediate Epithelial-Mesenchymal Transition and Are Dependent on the Transcriptional Co-Activator CAMP-Response Element-Binding Protein (CREB)-Binding Protein (CBP)","volume":"287","author":"Zhou","year":"2012","journal-title":"J Biol Chem"},{"issue":"7542","key":"10.1016\/j.bcp.2021.114812_b0305","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nature14208","article-title":"Cell Signalling: Disarming Wnt","volume":"519","author":"Nusse","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0310","doi-asserted-by":"crossref","first-page":"e2142","DOI":"10.1371\/journal.pone.0002142","article-title":"Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis","volume":"3","author":"K\u00f6nigshoff","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2021.114812_b0315","first-page":"1","article-title":"Distinct Roles of Wnt\/\u03b2-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis","volume":"2017","author":"Shi","year":"2017","journal-title":"Mediators Inflamm"},{"issue":"8","key":"10.1016\/j.bcp.2021.114812_b0320","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1820-x","article-title":"Autophagy Inhibition-Mediated Epithelial-Mesenchymal Transition Augments Local Myofibroblast Differentiation in Pulmonary Fibrosis","volume":"10","author":"Hill","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bcp.2021.114812_b0325","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cca.2019.12.016","article-title":"Autophagy, an Important Therapeutic Target for Pulmonary Fibrosis Diseases","volume":"502","author":"Zhao","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bcp.2021.114812_b0330","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3389\/fcell.2020.00747","article-title":"Endothelial-to-Mesenchymal Transition in Cancer","volume":"8","author":"Clere","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.bcp.2021.114812_b0335","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1165\/rcmb.2009-0031OC","article-title":"Endothelial-Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis","volume":"43","author":"Hashimoto","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"10.1016\/j.bcp.2021.114812_b0340","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/17476348.2020.1795832","article-title":"Endothelial to Mesenchymal Transition (EndMT) and Vascular Remodeling in Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis","volume":"14","author":"Gaikwad","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.bcp.2021.114812_b0345","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41419-021-03603-0","article-title":"Trajectory Modeling of Endothelial-to-Mesenchymal Transition Reveals Galectin-3 as a Mediator in Pulmonary Fibrosis","volume":"12","author":"Jia","year":"2021","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0350","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1164\/rccm.201106-0965OC","article-title":"Regulation of Transforming Growth Factor-\u03921-Driven Lung Fibrosis by Galectin-3","volume":"185","author":"MacKinnon","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bcp.2021.114812_b0355","doi-asserted-by":"crossref","first-page":"E798","DOI":"10.3390\/biom10050798","article-title":"Galectin-3: Roles in Neurodevelopment, Neuroinflammation, and Behavior","volume":"10","author":"Srejovic","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.bcp.2021.114812_b0360","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","article-title":"Guidelines and Definitions for Research on Epithelial-Mesenchymal Transition","volume":"21","author":"Yang","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bcp.2021.114812_b0365","article-title":"Mechanical and Physical Regulation of Fibroblast-Myofibroblast Transition: From Cellular Mechanoresponse to Tissue Pathology","volume":"8","author":"D\u2019Urso","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.bcp.2021.114812_b0370","doi-asserted-by":"crossref","unstructured":"Abdollahi, A.; Li, M.; Ping, G.; Plathow, C.; Domhan, S.; Kiessling, F.; Lee, L.B.; McMahon, G.; Gr\u00f6ne, H.-J.; Lipson, K.E.; et al. Inhibition of Platelet-Derived Growth Factor Signaling Attenuates Pulmonary Fibrosis. Journal of Experimental Medicine 2005, 201, 925\u2013935, doi:10.1084\/jem.20041393.","DOI":"10.1084\/jem.20041393"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0375","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1164\/rccm.2010014","article-title":"Basic Fibroblast Growth Factor and Its Receptors in Idiopathic Pulmonary Fibrosis and Lymphangioleiomyomatosis","volume":"166","author":"Inoue","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0380","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","article-title":"Evasion of Apoptosis by Myofibroblasts: A Hallmark of Fibrotic Diseases","volume":"16","author":"Hinz","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.bcp.2021.114812_b0385","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/acel.12514","article-title":"MTORC1 Activation Decreases Autophagy in Aging and Idiopathic Pulmonary Fibrosis and Contributes to Apoptosis Resistance in IPF Fibroblasts","volume":"15","author":"Romero","year":"2016","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.bcp.2021.114812_b0390","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yexcr.2018.01.019","article-title":"Elongation Factor-2 Kinase Acts Downstream of P38 MAPK to Regulate Proliferation, Apoptosis and Autophagy in Human Lung Fibroblasts","volume":"363","author":"Wang","year":"2018","journal-title":"Exp Cell Res"},{"issue":"13","key":"10.1016\/j.bcp.2021.114812_b0395","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.yexcr.2011.03.016","article-title":"Reversible Differentiation of Myofibroblasts by MyoD","volume":"317","author":"Hecker","year":"2011","journal-title":"Exp Cell Res"},{"issue":"13","key":"10.1016\/j.bcp.2021.114812_b0400","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1089\/ars.2013.5793","article-title":"The Lung Alveolar Lipofibroblast: An Evolutionary Strategy against Neonatal Hyperoxic Lung Injury","volume":"21","author":"Rehan","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"10.1016\/j.bcp.2021.114812_b0405","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.stem.2017.03.011","article-title":"Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis","volume":"20","author":"El Agha","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bcp.2021.114812_b0410","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.matbio.2015.06.003","article-title":"The Extracellular Matrix: Tools and Insights for the \u201cOmics\u201d Era","volume":"49","author":"Naba","year":"2016","journal-title":"Matrix Biol"},{"issue":"12","key":"10.1016\/j.bcp.2021.114812_b0415","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.3390\/ijms22126443","article-title":"Pulmonary Stretch and Lung Mechanotransduction: Implications for Progression in the Fibrotic Lung","volume":"22","author":"Marchioni","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bcp.2021.114812_b0420","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005017","article-title":"Cross Talk among TGF-\u03b2 Signaling Pathways, Integrins, and the Extracellular Matrix","volume":"3","author":"Munger","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"10.1016\/j.bcp.2021.114812_b0425","doi-asserted-by":"crossref","first-page":"L344","DOI":"10.1152\/ajplung.00300.2014","article-title":"Mechanosignaling through YAP and TAZ Drives Fibroblast Activation and Fibrosis","volume":"308","author":"Liu","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.bcp.2021.114812_b0430","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2147\/JIR.S280958","article-title":"Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis","volume":"13","author":"Michalski","year":"2020","journal-title":"J Inflamm Res"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0435","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.chest.2018.12.011","article-title":"Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease","volume":"155","author":"Adegunsoye","year":"2019","journal-title":"Chest"},{"issue":"7483","key":"10.1016\/j.bcp.2021.114812_b0440","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nature12807","article-title":"Muc5b Is Required for Airway Defence","volume":"505","author":"Roy","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2021.114812_b0445","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1164\/rccm.201902-0360OC","article-title":"Rare Protein-Altering Telomere-Related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis","volume":"200","author":"Ley","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"10082","key":"10.1016\/j.bcp.2021.114812_b0450","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic Pulmonary Fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b0455","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/01902148.2018.1455927","article-title":"MicroRNAs in Idiopathic Pulmonary Fibrosis, New Research Progress and Their Pathophysiological Implication","volume":"44","author":"Miao","year":"2018","journal-title":"Exp Lung Res"},{"issue":"20","key":"10.1016\/j.bcp.2021.114812_b0460","doi-asserted-by":"crossref","first-page":"12219","DOI":"10.1111\/jcmm.15853","article-title":"MiR-34a-5p Attenuates EMT through Targeting SMAD4 in Silica-Induced Pulmonary Fibrosis","volume":"24","author":"Qi","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0465","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89531-7","article-title":"Reconstruction of the MiR-506-Quaking Axis in Idiopathic Pulmonary Fibrosis Using Integrative Multi-Source Bioinformatics","volume":"11","author":"Stojanovi\u0107","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.bcp.2021.114812_b0470","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1096\/fj.201902063R","article-title":"SHIP-1, a Target of MiR-155, Regulates Endothelial Cell Responses in Lung Fibrosis","volume":"34","author":"Tang","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2021.114812_b0475","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41419-019-1339-1","article-title":"LncRNA ZEB1-AS1 Promotes Pulmonary Fibrosis through ZEB1-Mediated Epithelial-Mesenchymal Transition by Competitively Binding MiR-141-3p","volume":"10","author":"Qian","year":"2019","journal-title":"Cell Death Dis"},{"issue":"15","key":"10.1016\/j.bcp.2021.114812_b0480","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1111\/jcmm.16758","article-title":"LncRNA-ATB Regulates Epithelial-Mesenchymal Transition Progression in Pulmonary Fibrosis via Sponging MiR-29b-2-5p and MiR-34c-3p","volume":"25","author":"Xu","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bcp.2021.114812_b0485","doi-asserted-by":"crossref","first-page":"11313","DOI":"10.1038\/s41598-017-11904-8","article-title":"MiR-503 Modulates Epithelial-Mesenchymal Transition in Silica-Induced Pulmonary Fibrosis by Targeting PI3K P85 and Is Sponged by LncRNA MALAT1","volume":"7","author":"Yan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bcp.2021.114812_b0490","first-page":"1","article-title":"CircRNA TADA2A Relieves Idiopathic Pulmonary Fibrosis by Inhibiting Proliferation and Activation of Fibroblasts","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bcp.2021.114812_b0495","first-page":"3256","article-title":"Potential Regulatory Role of Circular RNA in Idiopathic Pulmonary Fibrosis","volume":"42","author":"Li","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bcp.2021.114812_b0500","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3390\/cells10071596","article-title":"Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics","volume":"10","author":"Brigstock","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2021.114812_b0505","doi-asserted-by":"crossref","unstructured":"Ceccarelli, L.; Marchetti, L.; Giacomelli, C.; Martini, C. Advances in Microglia Cellular Models: Focus on Extracellular Vesicle Production. Biochemical Society Transactions 2021, doi:10.1042\/BST20210203.","DOI":"10.1042\/BST20210203"},{"key":"10.1016\/j.bcp.2021.114812_b0510","doi-asserted-by":"crossref","unstructured":"Ceccarelli, L.; Giacomelli, C.; Marchetti, L.; Martini, C. Microglia Extracellular Vesicles: Focus on Molecular Composition and Biological Function. Biochem Soc Trans 2021, BST20210202, doi:10.1042\/BST20210202.","DOI":"10.1042\/BST20210202"},{"issue":"23","key":"10.1016\/j.bcp.2021.114812_b0515","doi-asserted-by":"crossref","first-page":"13913","DOI":"10.1111\/jcmm.15989","article-title":"Low Let-7d Exosomes from Pulmonary Vascular Endothelial Cells Drive Lung Pericyte Fibrosis through the TGF\u03b2RI\/FoxM1\/Smad\/\u03b2-Catenin Pathway","volume":"24","author":"Xie","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bcp.2021.114812_b0520","doi-asserted-by":"crossref","first-page":"117259","DOI":"10.1016\/j.envpol.2021.117259","article-title":"MiR-21 in EVs from Pulmonary Epithelial Cells Promotes Myofibroblast Differentiation via Glycolysis in Arsenic-Induced Pulmonary Fibrosis","volume":"286","author":"Wang","year":"2021","journal-title":"Environ Pollut"},{"key":"10.1016\/j.bcp.2021.114812_b0525","doi-asserted-by":"crossref","first-page":"115559","DOI":"10.1016\/j.taap.2021.115559","article-title":"SPP1 Derived from Silica-Exposed Macrophage Exosomes Triggers Fibroblast Transdifferentiation","volume":"422","author":"Huang","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bcp.2021.114812_b0530","doi-asserted-by":"crossref","first-page":"110253","DOI":"10.1016\/j.ecoenv.2020.110253","article-title":"Exosomal MiR-125a-5p Derived from Silica-Exposed Macrophages Induces Fibroblast Transdifferentiation","volume":"192","author":"Wang","year":"2020","journal-title":"Ecotoxicol Environ Saf"},{"issue":"22","key":"10.1016\/j.bcp.2021.114812_b0535","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.bcp.2021.114812_b0540","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bcp.2021.114812_b0545","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2213-2600(20)30355-6","article-title":"Progressive Fibrosing Interstitial Lung Disease: Clinical Uncertainties, Consensus Recommendations, and Research Priorities","volume":"8","author":"George","year":"2020","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.bcp.2021.114812_b0550","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12931-019-1269-6","article-title":"Ongoing Challenges in Pulmonary Fibrosis and Insights from the Nintedanib Clinical Programme","volume":"21","author":"Valenzuela","year":"2020","journal-title":"Respir. Res."},{"issue":"21","key":"10.1016\/j.bcp.2021.114812_b0555","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMoa042976","article-title":"High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis","volume":"353","author":"Demedts","year":"2005","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.bcp.2021.114812_b0560","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-07-6307","article-title":"BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy","volume":"68","author":"Hilberg","year":"2008","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.bcp.2021.114812_b0565","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/1759-7714.13437","article-title":"Effect of Nintedanib on Non-Small Cell Lung Cancer in a Patient with Idiopathic Pulmonary Fibrosis: A Case Report and Literature Review","volume":"11","author":"Shiratori","year":"2020","journal-title":"Thoracic Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0570","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of Action of Nintedanib in the Treatment of Idiopathic Pulmonary Fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bcp.2021.114812_b0575","article-title":"Molecular Mechanisms of Pirfenidone Activity in Human Lung Fibroblasts","volume":"44","author":"Conte","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.bcp.2021.114812_b0580","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7150\/ijms.11579","article-title":"Role and New Insights of Pirfenidone in Fibrotic Diseases","volume":"12","author":"Mora","year":"2015","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0585","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-016-0418-4","article-title":"Upregulation of RGS2: A New Mechanism for Pirfenidone Amelioration of Pulmonary Fibrosis","volume":"17","author":"Xie","year":"2016","journal-title":"Respir. Res."},{"issue":"15","key":"10.1016\/j.bcp.2021.114812_b0590","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.18632\/oncotarget.27526","article-title":"Pirfenidone Anti-Fibrotic Effects Are Partially Mediated by the Inhibition of MUC1 Bioactivation","volume":"11","author":"Ballester","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2021.114812_b0595","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.201411-2044ED","article-title":"New Antifibrotic Treatments Indicated for Idiopathic Pulmonary Fibrosis Offer Hopes and Raises Questions","volume":"191","author":"Raghu","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bcp.2021.114812_b0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2019.02.001","article-title":"Translational Research in Pulmonary Fibrosis","volume":"209","author":"Mathai","year":"2019","journal-title":"Translational Research"},{"issue":"7","key":"10.1016\/j.bcp.2021.114812_b0605","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/14712598.2020.1735346","article-title":"Antibody-Based Therapies for Idiopathic Pulmonary Fibrosis","volume":"20","author":"Sgalla","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.bcp.2021.114812_b0610","doi-asserted-by":"crossref","DOI":"10.21037\/sci.2019.06.09","article-title":"Cell-Based Therapy for Idiopathic Pulmonary Fibrosis","volume":"6","author":"Lu","year":"2019","journal-title":"Stem Cell Investigation"},{"key":"10.1016\/j.bcp.2021.114812_b0615","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1358\/dnp.2010.23.5.1444206","article-title":"PRM-151 (Recombinant Human Serum Amyloid P\/Pentraxin 2) for the Treatment of Fibrosis","volume":"23","author":"Duffield","year":"2010","journal-title":"Drug News Perspect"},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b0620","doi-asserted-by":"crossref","first-page":"e9683","DOI":"10.1371\/journal.pone.0009683","article-title":"Serum Amyloid P Therapeutically Attenuates Murine Bleomycin-Induced Pulmonary Fibrosis via Its Effects on Macrophages","volume":"5","author":"Murray","year":"2010","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.bcp.2021.114812_b0625","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S2213-2600(19)30172-9","article-title":"Long-Term Treatment with Recombinant Human Pentraxin 2 Protein in Patients with Idiopathic Pulmonary Fibrosis: An Open-Label Extension Study","volume":"7","author":"Raghu","year":"2019","journal-title":"The Lancet Respiratory Medicine"},{"issue":"7","key":"10.1016\/j.bcp.2021.114812_b0630","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/resp.12343","article-title":"A Phase 1b Study of Placenta-Derived Mesenchymal Stromal Cells in Patients with Idiopathic Pulmonary Fibrosis","volume":"19","author":"Chambers","year":"2014","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0635","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-11-171","article-title":"A Prospective, Non-Randomized, No Placebo-Controlled, Phase Ib Clinical Trial to Study the Safety of the Adipose Derived Stromal Cells-Stromal Vascular Fraction in Idiopathic Pulmonary Fibrosis","volume":"11","author":"Tzouvelekis","year":"2013","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0640","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.chest.2016.10.061","article-title":"Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial","volume":"151","author":"Glassberg","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0645","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/sctm.19-0037","article-title":"First-in-Human High-Cumulative-Dose Stem Cell Therapy in Idiopathic Pulmonary Fibrosis with Rapid Lung Function Decline","volume":"9","author":"Averyanov","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.bcp.2021.114812_b0650","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/sctm.19-0167","article-title":"A Pre-Investigational New Drug Study of Lung Spheroid Cell Therapy for Treating Pulmonary Fibrosis","volume":"9","author":"Cores","year":"2020","journal-title":"Stem Cells Transl Med"},{"issue":"129","key":"10.1016\/j.bcp.2021.114812_b0655","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1183\/09059180.00000713","article-title":"The Role of Infection in the Pathogenesis of Idiopathic Pulmonary Fibrosis","volume":"22","author":"Molyneaux","year":"2013","journal-title":"European Respiratory Review"},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b0660","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","article-title":"The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections","volume":"15","author":"Machhi","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"issue":"8","key":"10.1016\/j.bcp.2021.114812_b0665","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary Fibrosis and COVID-19: The Potential Role for Antifibrotic Therapy","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b0670","doi-asserted-by":"crossref","first-page":"e0248957","DOI":"10.1371\/journal.pone.0248957","article-title":"The Characteristics and Evolution of Pulmonary Fibrosis in COVID-19 Patients as Assessed by AI-Assisted Chest HRCT","volume":"16","author":"Zou","year":"2021","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.bcp.2021.114812_b0675","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S2213-2600(20)30222-8","article-title":"Pulmonary Fibrosis Secondary to COVID-19: A Call to Arms?","volume":"8","author":"Spagnolo","year":"2020","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.bcp.2021.114812_b0680","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5694\/mja2.50674","article-title":"COVID-19 Acute Respiratory Distress Syndrome (ARDS): Clinical Features and Differences from Typical Pre-COVID-19 ARDS","volume":"213","author":"Gibson","year":"2020","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0685","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24467-0","article-title":"Chronic Lung Diseases Are Associated with Gene Expression Programs Favoring SARS-CoV-2 Entry and Severity","volume":"12","author":"Bui","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0690","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/S2666-7568(20)30033-7","article-title":"Metformin and Risk of Mortality in Patients Hospitalised with COVID-19: A Retrospective Cohort Analysis","volume":"2","author":"Bramante","year":"2021","journal-title":"Lancet Healthy Longev"},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b0695","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s43440-021-00233-3","article-title":"In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality in Coronavirus-2019 (COVID-19): Systematic Review and Meta-Analysis","volume":"73","author":"Permana","year":"2021","journal-title":"Pharmacol Rep"},{"issue":"4","key":"10.1016\/j.bcp.2021.114812_b0700","doi-asserted-by":"crossref","first-page":"2003690","DOI":"10.1183\/13993003.03690-2020","article-title":"Pulmonary Function and Radiological Features 4 Months after COVID-19: First Results from the National Prospective Observational Swiss COVID-19 Lung Study","volume":"57","author":"Guler","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0705","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1148\/radiol.2021203153","article-title":"Six-Month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia","volume":"299","author":"Han","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.bcp.2021.114812_b0710","doi-asserted-by":"crossref","unstructured":"Fabbri, L.; Moss, S.; Khan, F.; Chi, W.; Xia, J.; Robinson, K.; Smyth, A.; Jenkins, G.; Stewart, I. Post-Viral Parenchymal Lung Disease of COVID-19 and Viral Pneumonitis: A Systematic Review and Meta-Analysis. medRxiv 2021, 2021.03.15.21253593, doi:10.1101\/2021.03.15.21253593.","DOI":"10.1101\/2021.03.15.21253593"},{"key":"10.1016\/j.bcp.2021.114812_b0715","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijid.2020.08.054","article-title":"First Report on Clinical and Radiological Features of COVID-19 Pneumonitis in a Caucasian Population: Factors Predicting Fibrotic Evolution","volume":"99","author":"Marvisi","year":"2020","journal-title":"International Journal of Infectious Diseases"},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b0720","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1148\/radiol.2283030726","article-title":"Thin-Section CT in Patients with Severe Acute Respiratory Syndrome Following Hospital Discharge: Preliminary Experience","volume":"228","author":"Antonio","year":"2003","journal-title":"Radiology"},{"issue":"Suppl 5","key":"10.1016\/j.bcp.2021.114812_b0725","doi-asserted-by":"crossref","first-page":"S417","DOI":"10.1513\/AnnalsATS.201605-341AW","article-title":"Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis","volume":"13","author":"Pardo","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.bcp.2021.114812_b0730","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.606462","article-title":"Senescence in Pulmonary Fibrosis: Between Aging and Exposure","author":"Venosa","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.bcp.2021.114812_b0735","article-title":"CT of Post-Acute Lung Complications of COVID-19","volume":"211396","author":"Solomon","year":"2021","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0740","article-title":"Long-Term Bone and Lung Consequences Associated with Hospital-Acquired Severe Acute Respiratory Syndrome: A 15-Year Follow-up from a Prospective Cohort Study","volume":"8","author":"Zhang","year":"2020","journal-title":"Bone Res"},{"issue":"10223","key":"10.1016\/j.bcp.2021.114812_b0745","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China. The Lancet"},{"issue":"4","key":"10.1016\/j.bcp.2021.114812_b0750","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1152\/physrev.00020.2020","article-title":"SARS-CoV-2 and COVID-19: From the Bench to the Bedside","volume":"100","author":"Romagnoli","year":"2020","journal-title":"Physiol. Rev."},{"issue":"11","key":"10.1016\/j.bcp.2021.114812_b0755","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41379-020-0603-3","article-title":"A Systematic Review of Pathological Findings in COVID-19: A Pathophysiological Timeline and Possible Mechanisms of Disease Progression","volume":"33","author":"Polak","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bcp.2021.114812_b0760","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02069","article-title":"Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider","volume":"11","author":"Garcia-Revilla","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114812_b0765","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological Inflammation in Patients with COVID-19: A Key Role for Monocytes and Macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0770","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0775","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18854-2","article-title":"Two Distinct Immunopathological Profiles in Autopsy Lungs of COVID-19","volume":"11","author":"Nienhold","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0780","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/imr.12977","article-title":"COVID-19 and Pulmonary Fibrosis: A Potential Role for Lung Epithelial Cells and Fibroblasts","volume":"302","author":"John","year":"2021","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b0785","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1440-1827.2003.01446.x","article-title":"Pulmonary Fibrosis: Cellular and Molecular Events","volume":"53","author":"Razzaque","year":"2003","journal-title":"Pathol Int"},{"key":"10.1016\/j.bcp.2021.114812_b0790","series-title":"Molecular Biology of the SARS-Coronavirus","first-page":"247","author":"Zuo","year":"2010"},{"issue":"21","key":"10.1016\/j.bcp.2021.114812_b0795","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell Entry Mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.bcp.2021.114812_b0800","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.bcp.2021.114812_b0805","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbrc.2004.05.114","article-title":"Susceptibility to SARS Coronavirus S Protein-Driven Infection Correlates with Expression of Angiotensin Converting Enzyme 2 and Infection Can Be Blocked by Soluble Receptor","volume":"319","author":"Hofmann","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"784","key":"10.1016\/j.bcp.2021.114812_b0810","first-page":"e1","article-title":"Angiotensin-Converting Enzyme 2 as the Molecular Bridge Between Epidemiologic and Clinical Features of COVID-19","volume":"36","author":"Bombardini","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.bcp.2021.114812_b0815","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00340","article-title":"SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis","author":"Delpino","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bcp.2021.114812_b0820","first-page":"100023","article-title":"Converging Pathways in Pulmonary Fibrosis and Covid-19 \u2013 The Fibrotic Link to Disease Severity","volume":"2","author":"Wig\u00e9n","year":"2020","journal-title":"Respir Med X"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0825","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12272-021-01331-9","article-title":"COVID-19 and Pulmonary Fibrosis: Therapeutics in Clinical Trials, Repurposing, and Potential Development","volume":"44","author":"Yim","year":"2021","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bcp.2021.114812_b0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-019-0147-9","article-title":"Alveolar Type 2 Progenitor Cells for Lung Injury Repair","volume":"5","author":"Olajuyin","year":"2019","journal-title":"Cell Death Discovery"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b0835","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the Cardiovascular Consequences","volume":"318","author":"South","year":"2020","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"10.1016\/j.bcp.2021.114812_b0840","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coph.2017.12.002","article-title":"Targeting the Renin-Angiotensin System as Novel Therapeutic Strategy for Pulmonary Diseases","volume":"40","author":"Tan","year":"2018","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0845","doi-asserted-by":"crossref","first-page":"L152","DOI":"10.1152\/ajplung.00455.2020","article-title":"Angiotensin-Converting Enzyme 2 Expression in COPD and IPF Fibroblasts: The Forgotten Cell in COVID-19","volume":"320","author":"Aloufi","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"7047","key":"10.1016\/j.bcp.2021.114812_b0850","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-Converting Enzyme 2 Protects from Severe Acute Lung Failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0855","doi-asserted-by":"crossref","first-page":"L178","DOI":"10.1152\/ajplung.00009.2008","article-title":"Angiotensin Converting Enzyme-2 Is Protective but Downregulated in Human and Experimental Lung Fibrosis","volume":"295","author":"Li","year":"2008","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"4","key":"10.1016\/j.bcp.2021.114812_b0860","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/path.2987","article-title":"Acute Respiratory Distress Syndrome Leads to Reduced Ratio of ACE\/ACE2 Activities and Is Prevented by Angiotensin-(1\u20137) or an Angiotensin II Receptor Antagonist","volume":"225","author":"W\u00f6sten-van Asperen","year":"2011","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.bcp.2021.114812_b0865","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.drudis.2021.04.006","article-title":"The Fight against COVID-19: Striking a Balance in the Renin-Angiotensin System","volume":"26","author":"Dean","year":"2021","journal-title":"Drug Discovery Today"},{"issue":"8","key":"10.1016\/j.bcp.2021.114812_b0870","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/ph14080805","article-title":"Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection","volume":"14","author":"Ambrocio-Ortiz","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bcp.2021.114812_b0875","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3390\/jcm10061200","article-title":"Angiotensin-(1\u20137)\u2014A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic","volume":"10","author":"Heyman","year":"2021","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.bcp.2021.114812_b0880","doi-asserted-by":"crossref","first-page":"103356","DOI":"10.1016\/j.ebiom.2021.103356","article-title":"The Duplicitous Nature of ACE2 in COVID-19 Disease","volume":"67","author":"Heyman","year":"2021","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.bcp.2021.114812_b0885","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.0022-202X.2005.23750.x","article-title":"Smad3 and Extracellular Signal-Regulated Kinase 1\/2 Coordinately Mediate Transforming Growth Factor-\u03b2-Induced Expression of Connective Tissue Growth Factor in Human Fibroblasts","volume":"124","author":"Leivonen","year":"2005","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.bcp.2021.114812_b0890","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12931-020-01445-6","article-title":"SARS-CoV-2 Induces Transcriptional Signatures in Human Lung Epithelial Cells That Promote Lung Fibrosis","volume":"21","author":"Xu","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.bcp.2021.114812_b0895","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41598-020-80010-z","article-title":"Plasma Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Hospitalized COVID-19 Patients","volume":"11","author":"Zuo","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bcp.2021.114812_b0900","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1523-1747.2002.01641.x","article-title":"Transforming Growth Factor-Beta Signaling through the Smad Pathway: Role in Extracellular Matrix Gene Expression and Regulation","volume":"118","author":"Verrecchia","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bcp.2021.114812_b0905","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12931-020-01590-y","article-title":"Can Biomarkers of Extracellular Matrix Remodelling and Wound Healing Be Used to Identify High Risk Patients Infected with SARS-CoV-2?: Lessons Learned from Pulmonary Fibrosis","volume":"22","author":"Leeming","year":"2021","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0910","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1118-7","article-title":"Biomarkers of Collagen Synthesis Predict Progression in the PROFILE Idiopathic Pulmonary Fibrosis Cohort","volume":"20","author":"Organ","year":"2019","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.bcp.2021.114812_b0915","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(15)00048-X","article-title":"Longitudinal Change in Collagen Degradation Biomarkers in Idiopathic Pulmonary Fibrosis: An Analysis from the Prospective, Multicentre PROFILE Study","volume":"3","author":"Jenkins","year":"2015","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.bcp.2021.114812_b0920","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1067-1927.2004.012111.x-1","article-title":"TGF Beta-like Regulation of Matrix Metalloproteinases by Anti-Transforming Growth Factor-Beta, and Anti-Transforming Growth Factor-Beta 1 Antibodies in Dermal Fibroblasts: Implications for Wound Healing","volume":"12","author":"Philips","year":"2004","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.bcp.2021.114812_b0925","doi-asserted-by":"crossref","unstructured":"Chun, H.J.; Coutavas, E.; Pine, A.B.; Lee, A.I.; Yu, V.L.; Shallow, M.K.; Giovacchini, C.X.; Mathews, A.M.; Stephenson, B.; Que, L.G.; et al. Immunofibrotic Drivers of Impaired Lung Function in Postacute Sequelae of SARS-CoV-2 Infection. JCI Insight 2021, 6, e148476, doi:10.1172\/jci.insight.148476.","DOI":"10.1172\/jci.insight.148476"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b0930","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","article-title":"Utility of KL-6\/MUC1 in the Clinical Management of Interstitial Lung Diseases","volume":"50","author":"Ishikawa","year":"2012","journal-title":"Respiratory Investigation"},{"issue":"8","key":"10.1016\/j.bcp.2021.114812_b0935","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2217\/bmm-2019-0545","article-title":"Krebs von Den Lungen-6 as a Biomarker for Disease Severity Assessment in Interstitial Lung Disease","volume":"14","author":"d\u2019Alessandro","year":"2020","journal-title":"A Comprehensive Review. Biomark Med"},{"key":"10.1016\/j.bcp.2021.114812_b0940","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2021.02.012","article-title":"Correlation of Krebs von Den Lungen-6 and Fibronectin with Pulmonary Fibrosis in Coronavirus Disease 2019","volume":"517","author":"Peng","year":"2021","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bcp.2021.114812_b0945","doi-asserted-by":"crossref","unstructured":"d\u2019Alessandro, M.; Bergantini, L.; Cameli, P.; Curatola, G.; Remediani, L.; Bennett, D.; Bianchi, F.; Perillo, F.; Volterrani, L.; Mazzei, M.A.; et al. Serial KL-6 Measurements in COVID-19 Patients. Intern Emerg Med 2021, doi:10.1007\/s11739-020-02614-7.","DOI":"10.1007\/s11739-020-02614-7"},{"issue":"11","key":"10.1016\/j.bcp.2021.114812_b0950","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1177\/154405910308201107","article-title":"Pro-Inflammatory Cytokines Up-Regulate MUC1 Gene Expression in Oral Epithelial Cells","volume":"82","author":"Li","year":"2003","journal-title":"J Dent Res"},{"issue":"2","key":"10.1016\/j.bcp.2021.114812_b0955","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/jmv.26406","article-title":"Elevated MUC1 and MUC5AC Mucin Protein Levels in Airway Mucus of Critical Ill COVID-19 Patients","volume":"93","author":"Lu","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bcp.2021.114812_b0960","doi-asserted-by":"crossref","unstructured":"Wilson, J.G.; Simpson, L.J.; Ferreira, A.-M.; Rustagi, A.; Roque, J.; Asuni, A.; Ranganath, T.; Grant, P.M.; Subramanian, A.; Rosenberg-Hasson, Y.; et al. Cytokine Profile in Plasma of Severe COVID-19 Does Not Differ from ARDS and Sepsis. JCI Insight 2020, 5, 140289, doi:10.1172\/jci.insight.140289.","DOI":"10.1172\/jci.insight.140289"},{"key":"10.1016\/j.bcp.2021.114812_b0965","doi-asserted-by":"crossref","first-page":"155618","DOI":"10.1016\/j.cyto.2021.155618","article-title":"Type 1 Inflammatory Endotype Relates to Low Compliance, Lung Fibrosis, and Severe Complications in COVID-19","volume":"148","author":"Hasegawa","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2021.114812_b0970","doi-asserted-by":"crossref","unstructured":"Donlan, A.N.; Sutherland, T.E.; Marie, C.; Preissner, S.; Bradley, B.T.; Carpenter, R.M.; Sturek, J.M.; Ma, J.Z.; Moreau, G.B.; Donowitz, J.R.; et al. IL-13 Is a Driver of COVID-19 Severity. medRxiv 2021, 2020.06.18.20134353, doi:10.1101\/2020.06.18.20134353.","DOI":"10.1172\/jci.insight.150107"},{"key":"10.1016\/j.bcp.2021.114812_b0975","doi-asserted-by":"crossref","unstructured":"Elizabeth A. Middleton Xue-Yan He Frederik Denorme Robert A. Campbell David Ng Steven P. Salvatore Maria Mostyka Amelia Baxter-Stoltzfus Alain C. Borczuk Massimo Loda Mark J. Cody Bhanu Kanth Manne Irina Portier Estelle S. Harris Aaron C. Petrey Ellen J. Beswick Aleah F. Caulin Anthony Iovino Lisa M. Abegglen Andrew S. Weyrich Matthew T. Rondina Mikala Egeblad Joshua D. Schiffman Christian Con Yost Neutrophil Extracellular Traps Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome 136 10 2020 1169 1179 10.1182\/blood.2020007008.","DOI":"10.1182\/blood.2020007008"},{"key":"10.1016\/j.bcp.2021.114812_b0980","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663303","article-title":"Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis","volume":"12","author":"Pandolfi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2021.114812_b0985","doi-asserted-by":"crossref","unstructured":"Skendros, P.; Mitsios, A.; Chrysanthopoulou, A.; Mastellos, D.C.; Metallidis, S.; Rafailidis, P.; Ntinopoulou, M.; Sertaridou, E.; Tsironidou, V.; Tsigalou, C.; et al. Complement and Tissue Factor\u2013Enriched Neutrophil Extracellular Traps Are Key Drivers in COVID-19 Immunothrombosis. J Clin Invest 2020, 130, 6151\u20136157, doi:10.1172\/JCI141374.","DOI":"10.1172\/JCI141374"},{"key":"10.1016\/j.bcp.2021.114812_b0990","doi-asserted-by":"crossref","unstructured":"Veras, F.P.; Pontelli, M.C.; Silva, C.M.; Toller-Kawahisa, J.E.; de Lima, M.; Nascimento, D.C.; Schneider, A.H.; Caetit\u00e9, D.; Tavares, L.A.; Paiva, I.M.; et al. SARS-CoV-2\u2013Triggered Neutrophil Extracellular Traps Mediate COVID-19 Pathology. J Exp Med 2020, 217, e20201129, doi:10.1084\/jem.20201129.","DOI":"10.1084\/jem.20201129"},{"issue":"2","key":"10.1016\/j.bcp.2021.114812_b0995","doi-asserted-by":"crossref","first-page":"111486","DOI":"10.1016\/j.yexcr.2019.06.031","article-title":"NETs Promote ALI\/ARDS Inflammation by Regulating Alveolar Macrophage Polarization","volume":"382","author":"Song","year":"2019","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.bcp.2021.114812_b1000","doi-asserted-by":"crossref","first-page":"100113","DOI":"10.1016\/j.mcpro.2021.100113","article-title":"Proteome Profiling of Recombinant DNase Therapy in Reducing NETs and Aiding Recovery in COVID-19 Patients","volume":"20","author":"Fisher","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bcp.2021.114812_b1005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/cells10010151","article-title":"Significance of NETs Formation in COVID-19","volume":"10","author":"Janiuk","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.bcp.2021.114812_b1010","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","article-title":"Tissue Damage from Neutrophil-Induced Oxidative Stress in COVID-19","volume":"20","author":"Laforge","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bcp.2021.114812_b1015","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.615984","article-title":"Neutrophil Extracellular Traps in SARS-CoV2 Related Pneumonia in ICU Patients: The NETCOV2 Study","author":"Godement","year":"2021","journal-title":"Front. Med."},{"issue":"4","key":"10.1016\/j.bcp.2021.114812_b1020","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-Acute COVID-19 Syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b1025","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ajpath.2016.01.018","article-title":"Mechanisms of Lung Fibrosis Resolution","volume":"186","author":"Glasser","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2021.114812_b1030","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202002120","article-title":"Telomerase Treatment Prevents Lung Profibrotic Pathologies Associated with Physiological Aging","volume":"219","author":"Pi\u00f1eiro-Hermida","year":"2020","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2021.114812_b1035","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nrd.2017.225","article-title":"Emerging Therapies for Idiopathic Pulmonary Fibrosis, a Progressive Age-Related Disease","volume":"16","author":"Mora","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b1040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","article-title":"Pamrevlumab, an Anti-Connective Tissue Growth Factor Therapy, for Idiopathic Pulmonary Fibrosis (PRAISE): A Phase 2, Randomised, Double-Blind","volume":"8","author":"Richeldi","year":"2020","journal-title":"Placebo-Controlled Trial. The Lancet Respiratory Medicine"},{"issue":"2","key":"10.1016\/j.bcp.2021.114812_b1045","doi-asserted-by":"crossref","first-page":"1902442","DOI":"10.1183\/13993003.02442-2019","article-title":"Phase 2 Trial to Assess Lebrikizumab in Patients with Idiopathic Pulmonary Fibrosis","volume":"57","author":"Maher","year":"2021","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b1050","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12015-020-09976-7","article-title":"CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement","volume":"16","author":"Ulrich","year":"2020","journal-title":"Stem Cell Rev and Rep"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b1055","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00408-012-9410-z","article-title":"Treatment of Idiopathic Pulmonary Fibrosis with Losartan: A Pilot Project","volume":"190","author":"Couluris","year":"2012","journal-title":"Lung"},{"issue":"12","key":"10.1016\/j.bcp.2021.114812_b1060","doi-asserted-by":"crossref","first-page":"e0244708","DOI":"10.1371\/journal.pone.0244708","article-title":"Safety, Tolerability, and Outcomes of Losartan Use in Patients Hospitalized with SARS-CoV-2 Infection: A Feasibility Study","volume":"15","author":"Bolotova","year":"2020","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b1065","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1183\/09031936.00105314","article-title":"Oral Immunotherapy with Type V Collagen in Idiopathic Pulmonary Fibrosis","volume":"45","author":"Wilkes","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bcp.2021.114812_b1070","doi-asserted-by":"crossref","first-page":"110622","DOI":"10.1016\/j.biopha.2020.110622","article-title":"Propolis and Its Potential against SARS-CoV-2 Infection Mechanisms and COVID-19 Disease: Running Title: Propolis against SARS-CoV-2 Infection and COVID-19","volume":"131","author":"Berretta","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"10.1016\/j.bcp.2021.114812_b1075","doi-asserted-by":"crossref","first-page":"2002559","DOI":"10.1183\/13993003.02559-2020","article-title":"Target Inhibition of Galectin-3 by Inhaled TD139 in Patients with Idiopathic Pulmonary Fibrosis","volume":"57","author":"Hirani","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b1080","article-title":"JNK Inhibition Reduces Lung Remodeling and Pulmonary Fibrotic Systemic Markers","volume":"5","author":"Velden","year":"2016","journal-title":"Clinical and Translational Medicine"},{"key":"10.1016\/j.bcp.2021.114812_b1085","article-title":"CC-90001, a Second Generation Jun N-Terminal Kinase (JNK) Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis","author":"Bennett","year":"2017","journal-title":"In C38. UNDERSTANDING THERAPEUTICS IN IPF; American Thoracic Society International Conference Abstracts; American Thoracic Society"},{"key":"10.1016\/j.bcp.2021.114812_b1090","article-title":"LPA1 Antagonist BMS-986278 for Idiopathic Pulmonary Fibrosis: Preclinical Pharmacological in Vitro and in Vivo Evaluation","volume":"54","author":"Murphy","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.bcp.2021.114812_b1095","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-2600(18)30181-4","article-title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLPG1690, a Novel Autotaxin Inhibitor, to Treat Idiopathic Pulmonary Fibrosis (FLORA): A Phase 2a Randomised Placebo-Controlled Trial","volume":"6","author":"Maher","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.bcp.2021.114812_b1100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/jpet.114.216044","article-title":"Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis","volume":"351","author":"Hu","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.bcp.2021.114812_b1105","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S2213-2600(21)00222-8","article-title":"Colchicine for Community-Treated Patients with COVID-19 (COLCORONA): A Phase 3, Randomised, Double-Blinded, Adaptive, Placebo-Controlled","volume":"9","author":"Tardif","year":"2021","journal-title":"Multicentre Trial. The Lancet Respiratory Medicine"},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b1110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.chest.2016.03.021","article-title":"Safety and Tolerability of Alveolar Type II Cell Transplantation in Idiopathic Pulmonary Fibrosis","volume":"150","author":"Serrano-Mollar","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.bcp.2021.114812_b1115","article-title":"A Novel siRNA-Based Oligonucleotide, TRK-250, and Its Efficacy for Treatment of Idiopathic Pulmonary Fibrosis (IPF). In C64. PULMONARY FIBROSIS MODELS AND MECHANISTIC INSIGHTS","author":"Shibata","year":"2019","journal-title":"American Thoracic Society International Conference Abstracts; American Thoracic Society"},{"issue":"6","key":"10.1016\/j.bcp.2021.114812_b1120","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.nano.2017.04.005","article-title":"Combinatorial Treatment of Idiopathic Pulmonary Fibrosis Using Nanoparticles with Prostaglandin E and SiRNA(s)","volume":"13","author":"Garbuzenko","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2021.114812_b1125","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.7150\/thno.48152","article-title":"Suppressing Sart1 to Modulate Macrophage Polarization by SiRNA-Loaded Liposomes: A Promising Therapeutic Strategy for Pulmonary Fibrosis","volume":"11","author":"Pan","year":"2021","journal-title":"Theranostics"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:32:35Z","timestamp":1757770355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221004287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":225,"alternative-id":["S0006295221004287"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114812","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114812"}}